A Prospective Study of Drug Utilization and Evaluation of Gastro Intestinal Agents Sumithra M.1,*, Prabhabanik Avantika2 1Assistant Professor, Department of Pharmaceutical Chemistry and Analysis, Vels University (VISTAS), Chennai-600117 2Scholar, Pharm D, Department of Pharmacy Practice, Vels University (VISTAS), Chennai-600117 *Corresponding Author E-mail: sumithrapharmanalysis@gmail.com
Online published on 29 April, 2017. Abstract Objective A study was conducted to evaluate drug utilization of gastrointestinal agents in pediatric and geriatric patients. Methods Randomly selected 150 patients of gastrointestinal diseases with 92 male and 58 female of age from 15–58 underwent drug utilization evaluation of gastrointestinal agents. The frequencies of gastrointestinal agents were calculated and compared WHO indicators of DUS (drug utilization study) guidelines. Results Results include patients on long term gastrointestinal drug therapy on geriartric patient, paediatric patient. It include 92 male and 58 female patients in which 38.66% of female patient was and 61.335 of male patient suffered from gastrointestinal diseases. Out of 150 patients21.33% of patients was treated with pantoprazole, 12% of patients was treated with esomeprazole, 28.66% of patients was treated with omeprazole, 10.66% of patients was treated with rabeprazole, 27.33% of patients was treated with ranitidine. Oral route of administration was more than parenteral administration. Gastritis is occurred more than inflammatory bowel disease, peptic ulcer disease and gastroesophageal reflux disease Top Keywords Drug efficacy, GIT agents, Proton pump inhibitor, Gastritis. Top |